$Correlation between biological effective dose and radiation-induced liver disease from hypofractionated radiotherapy$

Correlation between biological effective dose and radiation-induced liver disease from hypofractionated radiotherapy

Background: The prevention of radiation-induced liver disease (RILD) is very significant in ensuring a safe radiation treatment and high quality of life. Aims and Objectives: The purpose of this study is to investigate the correlation of physical and biological effective dose (BED) metrics with live...

Full description

Bibliographic Details
Main Authors:	Angelo M Bergamo, Kevin Kauweloa, Gregory Gan, Zheng Shi, Janeen Daniels, Richard Crownover, Ganesh Narayanasamy, Sotirios Stathakis, Panayiotis Mavroidis, Niko Papanikolaou, Alonso Gutierrez
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Journal of Medical Physics
Subjects:	Biological effective dose Common Terminology Criteria for Adverse Events hypofractionated radiation-induced liver disease stereotactic body radiation therapy toxicity analysis
Online Access:	http://www.jmp.org.in/article.asp?issn=0971-6203;year=2019;volume=44;issue=3;spage=185;epage=190;aulast=Bergamo

Similar Items

Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients – early results of a phase II trial.
by: Scott eFloyd, et al.
Published: (2012-10-01)

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
by: Osama Mohamad, et al.
Published: (2018-07-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01)

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
by: Carlo Greco
Published: (2013-09-01)

Cost Minimization Analysis of Hypofractionated Radiotherapy
by: Hannah L. Yaremko, et al.
Published: (2021-01-01)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
by: Jiang Xue-song, et al.
Published: (2012-03-01)

Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation
by: Laurence Mengue, et al.
Published: (2020-04-01)

Clinical evaluation of a two-dimensional liquid-filled ion chamber detector array for verification of high modulation small fields in radiotherapy
by: Miljenko Markovic, et al.
Published: (2019-01-01)

Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer
by: Gabriella Rossi, et al.
Published: (2021-04-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2021-12-01)

A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes
by: Amit Maity, et al.
Published: (2021-01-01)

Hypofractionated conformal stereotactic radiotherapy in the treatment of AVMs and cerebral metastases
by: Lindvall, Peter
Published: (2006)

A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer
by: Shivaprasad Deshmukh, et al.
Published: (2016-07-01)

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study
by: Shivam M. Kharod, MD, et al.
Published: (2020-11-01)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
by: Geoffrey Martinage, et al.
Published: (2019-03-01)

Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review
by: Joseph W. Clyde, et al.
Published: (2019-10-01)

A dose falloff gradient study in RapidArc planning of lung stereotactic body radiation therapy
by: Ganesh Narayanasamy, et al.
Published: (2018-01-01)

Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer
by: Wang SW, et al.
Published: (2016-08-01)

A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis
by: Jill S. Remick, et al.
Published: (2020-05-01)

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT
by: Junyue Shen, et al.
Published: (2021-06-01)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
by: Alexandre Taillez, et al.
Published: (2021-07-01)

TOXICITY OF HYPOFRACTIONATED RADIATION THERAPY FOR LOCALLY ADVANCED PROSTATE CANCER
by: Kushnerova E. V., et al.
Published: (2019-09-01)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
by: Conti Alfredo, et al.
Published: (2019-11-01)

Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
by: Lee Dong, et al.
Published: (2012-06-01)

Current status and recent advances in resection cavity irradiation of brain metastases
by: Giuseppe Minniti, et al.
Published: (2021-04-01)

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
by: Byung Min Lee, et al.
Published: (2020-02-01)

Hypofractionated Radiation Therapy for Large Brain Metastases
by: Giuseppina Laura Masucci
Published: (2018-10-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Hemostatic radiotherapy
by: Aastha Shah, et al.
Published: (2021-01-01)

Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer
by: Robert eMeier
Published: (2015-04-01)

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
by: Matthew Richardson, et al.
Published: (2018-05-01)

Dose calculation comparisons between three modern treatment planning systems
by: Courtney Bosse, et al.
Published: (2020-01-01)

A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients
by: Kartick Rastogi, et al.
Published: (2018-01-01)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
by: Khush S. Aujla, et al.
Published: (2019-02-01)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
by: Donatella Arpa, et al.
Published: (2021-03-01)

Accelerated Hypofractionated Whole Breast Radiotherapy for Early Breast Cancer; A Randomized Phase III Clinical Trial
by: Sare Hosseini, et al.
Published: (2020-05-01)

Diversity of Clinically Relevant Outcomes Resulting from Hypofractionated Radiation in Human Glioma Stem Cells Mirrors Distinct Patterns of Transcriptomic Changes
by: Darius Kalasauskas, et al.
Published: (2020-03-01)

Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer
by: G. V. Afonin, et al.
Published: (2018-08-01)

Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists
by: Shearwood McClelland III, et al.

Cannot write session to /tmp/vufind_sessions/sess_nhh21t4ojbcjb3jl3dva67h7dq